Tag Archives: ROK

Hot Bank Stocks To Buy Right Now

Roosevelt Investment Group Inc. grew its position in Pfizer (NYSE:PFE) by 14.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 549,252 shares of the biopharmaceutical company’s stock after purchasing an additional 68,162 shares during the quarter. Pfizer makes up approximately 1.8% of Roosevelt Investment Group Inc.’s portfolio, making the stock its 18th largest holding. Roosevelt Investment Group Inc.’s holdings in Pfizer were worth $19,894,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in PFE. Delta Asset Management LLC TN raised its position in shares of Pfizer by 5.7% in the third quarter. Delta Asset Management LLC TN now owns 44,337 shares of the biopharmaceutical company’s stock valued at $1,583,000 after purchasing an additional 2,381 shares during the period. Lyell Wealth Management LP raised its position in shares of Pfizer by 3.8% in the third quarter. Lyell Wealth Management LP now owns 86,112 shares of the biopharmaceutical company’s stock valued at $3,074,000 after purchasing an additional 3,190 shares during the period. Callahan Advisors LLC raised its position in shares of Pfizer by 2.6% in the third quarter. Callahan Advisors LLC now owns 289,776 shares of the biopharmaceutical company’s stock valued at $10,345,000 after purchasing an additional 7,240 shares during the period. Hudock Capital Group LLC raised its position in shares of Pfizer by 4.5% in the third quarter. Hudock Capital Group LLC now owns 82,272 shares of the biopharmaceutical company’s stock valued at $2,937,000 after purchasing an additional 3,510 shares during the period. Finally, Parkside Financial Bank & Trust raised its position in shares of Pfizer by 5.8% in the third quarter. Parkside Financial Bank & Trust now owns 39,144 shares of the biopharmaceutical company’s stock valued at $1,398,000 after purchasing an additional 2,159 shares during the period. 71.50% of the stock is currently owned by institutional investors.

Hot Bank Stocks To Buy Right Now: Omega Flex Inc.(OFLX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Omega Flex, Inc. (NASDAQ:OFLX) announced a quarterly dividend on Wednesday, September 12th, Wall Street Journal reports. Shareholders of record on Friday, September 21st will be paid a dividend of 0.24 per share by the industrial products company on Tuesday, October 2nd. This represents a $0.96 annualized dividend and a yield of 1.28%. The ex-dividend date is Thursday, September 20th.

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Omega Flex (NASDAQ:OFLX) from a strong-buy rating to a buy rating in a research note published on Saturday.

    Shares of Omega Flex stock opened at $64.52 on Friday. The company has a market capitalization of $640.63 million, a P/E ratio of 34.69 and a beta of 1.07. Omega Flex has a 52 week low of $51.02 and a 52 week high of $95.00.

  • [By Peter Graham]

    Manufacturing and “made in America” is back with small cap Omega Flex, Inc (NASDAQ: OFLX) being one stock that’s clearly leading the way on the technical charts:

Hot Bank Stocks To Buy Right Now: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Gideon Capital Advisors Inc. bought a new position in shares of Rockwell Automation (NYSE:ROK) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 3,423 shares of the industrial products company’s stock, valued at approximately $596,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Rockwell Automation (ROK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Rockwell Automation (NYSE:ROK) VP Susan Schmitt sold 4,500 shares of the business’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $175.02, for a total transaction of $787,590.00. Following the sale, the vice president now owns 15,967 shares of the company’s stock, valued at approximately $2,794,544.34. The sale was disclosed in a legal filing with the SEC, which is available at this link.

  • [By Stephan Byrd]

    Oppenheimer & Co. Inc. grew its stake in shares of Rockwell Automation (NYSE:ROK) by 9.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,037 shares of the industrial products company’s stock after buying an additional 168 shares during the period. Oppenheimer & Co. Inc.’s holdings in Rockwell Automation were worth $307,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Sturgeon Ventures LLP lowered its position in shares of Rockwell Automation (NYSE:ROK) by 15.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 41,304 shares of the industrial products company’s stock after selling 7,320 shares during the period. Rockwell Automation comprises about 7.0% of Sturgeon Ventures LLP’s holdings, making the stock its 6th largest position. Sturgeon Ventures LLP’s holdings in Rockwell Automation were worth $6,874,000 at the end of the most recent reporting period.

Hot Bank Stocks To Buy Right Now: Stoneridge Inc.(SRI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Stoneridge, Inc. (NYSE:SRI) have earned a consensus rating of “Buy” from the nine research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $31.40.

  • [By Motley Fool Transcribers]

    Stoneridge Inc  (NYSE:SRI)Q4 2018 Earnings Conference CallFeb. 28, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Cubist Systematic Strategies LLC purchased a new stake in Stoneridge, Inc. (NYSE:SRI) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,757 shares of the auto parts company’s stock, valued at approximately $214,000.

  • [By Shane Hupp]

    Shares of Stoneridge, Inc. (NYSE:SRI) have earned an average recommendation of “Buy” from the eight research firms that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $30.50.

  • [By Ethan Ryder]

    Stoneridge, Inc. (NYSE:SRI) – Analysts at B. Riley lowered their Q3 2019 earnings estimates for Stoneridge in a note issued to investors on Friday, March 1st. B. Riley analyst C. Horn now forecasts that the auto parts company will earn $0.50 per share for the quarter, down from their prior forecast of $0.55. B. Riley also issued estimates for Stoneridge’s Q4 2019 earnings at $0.51 EPS, Q1 2020 earnings at $0.50 EPS, Q2 2020 earnings at $0.50 EPS, Q3 2020 earnings at $0.52 EPS, Q4 2020 earnings at $0.54 EPS and FY2020 earnings at $2.07 EPS.

Best Performing Stocks To Buy For 2019

Target (NYSE:TGT) stock seemed to be finally turning a corner. After years of pressure from e-commerce giant Amazon and Walmart’s digital reinvention, shares were significantly trailing the greater S&P 500 and posting a 5-year loss. Over the last year, however, shares have rallied in response to management’s plans to reinvigorate the brand’s shopping experience and improve its online shopping channel. 

Unfortunately, the company’s first-quarter earnings put a halt to that rally. Target had a mixed report, outperforming on the top line with $16.8 billion in revenue but missing on the bottom line with adjusted earnings per share of $1.32 versus the analyst consensus of $1.39. Looking beyond the headline numbers, there are signs of improvement: Same-store sales increased by 3% during the quarter, and digital sales increased 28%, a higher clip than the 21% growth rate in the year-ago period.

Still, shares are down 6% this week. Is this a good time for value investors to establish a position?

Best Performing Stocks To Buy For 2019: Catalyst Pharmaceuticals, Inc.(CPRX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Joseph Griffin]

    Cantor Fitzgerald assumed coverage on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) in a report issued on Thursday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $8.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 153.97% from the stock’s current price.

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) from a sell rating to a strong sell rating in a report published on Wednesday morning.

  • [By Shane Hupp]

    Cantor Fitzgerald assumed coverage on shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) in a report issued on Thursday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $8.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 153.97% from the stock’s current price.

  • [By Joseph Griffin]

    Shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) have received a consensus rating of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $6.25.

  • [By Stephan Byrd]

    BidaskClub cut shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) from a hold rating to a sell rating in a report published on Tuesday.

    CPRX has been the subject of several other research reports. HC Wainwright set a $6.00 target price on Catalyst Pharmaceuticals and gave the stock a buy rating in a research report on Wednesday, August 22nd. Zacks Investment Research raised Catalyst Pharmaceuticals from a hold rating to a buy rating and set a $3.25 target price for the company in a research report on Monday, August 13th. Oppenheimer started coverage on Catalyst Pharmaceuticals in a research report on Thursday, July 12th. They issued a buy rating and a $6.00 target price for the company. Cantor Fitzgerald started coverage on Catalyst Pharmaceuticals in a research report on Friday, September 21st. They issued an overweight rating for the company. Finally, Piper Jaffray Companies started coverage on Catalyst Pharmaceuticals in a research report on Friday, September 7th. They issued an overweight rating and a $5.00 target price for the company. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. The company has an average rating of Hold and an average price target of $5.61.

Best Performing Stocks To Buy For 2019: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Lee Samaha]

    In truth, there’s nothing surprising here, because a slew of companies have reported weaker automotive capital spending conditions. For example, Rockwell Automation (NYSE:ROK) recently lowered expectations for its sales to the industry in 2019. 

  • [By Joseph Griffin]

    Rockwell Automation (NYSE: ROK) and Oxford Instruments (OTCMKTS:OXINF) are both industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations.

  • [By Lee Samaha]

    Investing in robotics is a popular idea, but sometimes you have to dig a bit deeper to find stocks exposed to the theme. In this context, I think Cognex Corporation’s (NASDAQ:CGNX) machine vision solutions, Rockwell Automation Inc.’s (NYSE:ROK) industrial automation technology, and NICE Ltd.’s (NASDAQ:NICE) data analytics and artificial intelligence (AI) are well suited to profit from increased spending on robotics. Let’s look at the case for each of the three.

Best Performing Stocks To Buy For 2019: Internet Gold Golden Lines Ltd.(IGLD)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Internet Gold Golden Lines (NASDAQ:IGLD) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Internet Gold Golden Lines earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 47.7616640405736 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Best Performing Stocks To Buy For 2019: Engility Holdings, Inc.(EGL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s analysis:

    Get Engility alerts:

    Engility CEO Lynn Dugle Named Among ‘Outstanding Women in STEM’ (govconwire.com) Analysts Set Expectations for Engility Holdings Inc’s Q3 2018 Earnings (EGL) (americanbankingnews.com) Engility Holdings Inc Forecasted to Post Q3 2018 Earnings of $0.47 Per Share (EGL) (americanbankingnews.com) Engility to Present at the Jefferies 2018 Global Industrials Conference (finance.yahoo.com) Engility (EGL) Downgraded to Hold at Noble Financial (americanbankingnews.com)

    A number of brokerages recently weighed in on EGL. Noble Financial downgraded Engility from a “buy” rating to a “hold” rating and set a $37.00 price objective on the stock. in a research report on Thursday, August 2nd. Wells Fargo & Co raised their price objective on Engility from $27.00 to $35.00 and gave the company a “market perform” rating in a research report on Friday, July 13th. ValuEngine raised Engility from a “hold” rating to a “buy” rating in a research report on Thursday, July 12th. Cowen set a $40.00 price objective on Engility and gave the company a “buy” rating in a research report on Wednesday, August 1st. Finally, Drexel Hamilton reaffirmed a “hold” rating on shares of Engility in a research report on Wednesday, August 1st. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Engility has an average rating of “Buy” and an average price target of $37.50.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Engility (EGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Daniel Sparks]

    The stock’s decline followed SAIC’s better-than-expected second-quarter results, as well as an announcement from SAIC that it’s acquiring Engility Holdings (NYSE:EGL), a staffing and outsourcing services company. The acquisition, which is valued at $2.5 billion when including the assumption of Engility’s $900 million in debt, is a significant undertaking given that SAIC’s total market capitalization is only around $3.5 billion.

  • [By Lou Whiteman]

    Science Applications International Corp. (NYSE:SAIC) has joined the stampede of government services firms expanding via acquisition, agreeing Sept. 10 to acquire Engility Holdings (NYSE:EGL) for about $2.5 billion in stock and assumed debt.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Engility (EGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Financial Stocks To Own Right Now

Principal Financial Group Inc. reduced its position in AES Corp (NYSE:AES) by 0.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 970,303 shares of the utilities provider’s stock after selling 7,304 shares during the quarter. Principal Financial Group Inc. owned approximately 0.15% of AES worth $11,033,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Alliancebernstein L.P. increased its position in AES by 11.1% in the fourth quarter. Alliancebernstein L.P. now owns 1,503,377 shares of the utilities provider’s stock worth $16,282,000 after buying an additional 149,883 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. grew its position in shares of AES by 136.1% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 29,554 shares of the utilities provider’s stock valued at $319,000 after purchasing an additional 17,034 shares in the last quarter. Mackenzie Financial Corp grew its position in shares of AES by 328.2% in the fourth quarter. Mackenzie Financial Corp now owns 580,771 shares of the utilities provider’s stock valued at $6,290,000 after purchasing an additional 445,147 shares in the last quarter. Ellington Management Group LLC purchased a new position in shares of AES in the fourth quarter valued at $1,989,000. Finally, Two Sigma Investments LP grew its position in shares of AES by 166.4% in the fourth quarter. Two Sigma Investments LP now owns 2,621,643 shares of the utilities provider’s stock valued at $28,392,000 after purchasing an additional 1,637,712 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Top Financial Stocks To Own Right Now: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Oppenheimer & Co. Inc. grew its stake in shares of Rockwell Automation (NYSE:ROK) by 9.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,037 shares of the industrial products company’s stock after buying an additional 168 shares during the period. Oppenheimer & Co. Inc.’s holdings in Rockwell Automation were worth $307,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Rockwell Automation (NYSE: ROK) and Oxford Instruments (OTCMKTS:OXINF) are both industrial products companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations.

  • [By Logan Wallace]

    Rockwell Automation (NYSE:ROK) VP Susan Schmitt sold 4,500 shares of the business’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $175.02, for a total transaction of $787,590.00. Following the sale, the vice president now owns 15,967 shares of the company’s stock, valued at approximately $2,794,544.34. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Top Financial Stocks To Own Right Now: Innovative Industrial Properties, Inc. (IIPR)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    There’s no question about it, marijuana is a very hot topic on Wall Street. With all the hype flying around, you might be tempted to jump aboard and buy a pot stock. However, you don’t actually need to do that to gain exposure to the industry and what is expected to be massive growth in demand. Instead, you can buy a supplier to the marijuana industry like The Scotts Miracle-Gro Company (NYSE:SMG) or Innovative Industrial Properties, Inc. (NYSE:IIPR). But which of these two is the better buy?

  • [By Dan Caplinger]

    Marijuana stocks have become exceedingly popular, but not everyone feels comfortable investing directly in the companies that produce and grow cannabis. Instead, some prefer to look at the companies that are in the business of helping marijuana producers maximize their growth business. Scotts Miracle-Gro (NYSE:SMG) provides fertilizers and equipment that individual and commercial operations can use to boost cannabis production, while Innovative Industrial Properties (NYSE:IIPR) is a real estate investment trust designed to help cannabis companies find the space they need while meeting all the regulatory requirements surrounding marijuana production facilities.

  • [By Sean Williams]

    If you want exposure to the fast-paced marijuana industry without the ups and downs that could come with harvesting the plant, small-cap real estate investment trust (REIT) Innovative Industrial Properties (NYSE:IIPR) could be a winner.

  • [By Sean Williams]

    If you’re looking for a reason behind the strong performance for marijuana-based real-estate investment trust (REIT) Innovative Industrial Properties (NYSE:IIPR), chalk it up to uniqueness. There’s simply no other publicly traded company (of reasonable size, by market cap) at the moment that operates with a REIT structure in the cannabis space.

Top Financial Stocks To Own Right Now: CNB Financial Corporation(CCNE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Thursday morning.

    A number of other research analysts have also recently issued reports on CCNE. ValuEngine cut shares of CNB Financial from a strong-buy rating to a buy rating in a report on Wednesday, May 2nd. Zacks Investment Research raised shares of CNB Financial from a sell rating to a hold rating in a report on Thursday, June 14th. Boenning Scattergood reaffirmed a buy rating on shares of CNB Financial in a report on Tuesday, April 17th. Finally, Keefe, Bruyette & Woods assumed coverage on shares of CNB Financial in a report on Tuesday, April 10th. They issued a market perform rating and a $35.00 price target for the company. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average price target of $31.50.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CNB Financial (CCNE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Wednesday morning.

    Several other equities research analysts have also issued reports on CCNE. Boenning Scattergood reissued a buy rating and set a $29.50 price target on shares of CNB Financial in a research report on Monday, February 5th. Zacks Investment Research lowered CNB Financial from a buy rating to a sell rating in a research report on Tuesday, February 20th. ValuEngine raised CNB Financial from a buy rating to a strong-buy rating in a research report on Monday, April 2nd. Finally, Keefe, Bruyette & Woods initiated coverage on CNB Financial in a research report on Tuesday, April 10th. They set a market perform rating and a $35.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $31.50.

  • [By Ethan Ryder]

    CNB Financial (NASDAQ:CCNE) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “CNB Financial (CCNE) Rating Lowered to Sell at Zacks Investment Research” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3370450/cnb-financial-ccne-rating-lowered-to-sell-at-zacks-investment-research.html.

Top 10 Performing Stocks For 2018

Source: ThinkstockNovember 29, 2017: The S&P 500 closed relatively flat at 2,626.03. The DJIA closed up 0.4% at 23,940.24. Separately, the Nasdaq was down 1.3% at 6,824.34.

Wednesday was a mixed day for U.S. broad markets in general. While the Dow cruised to new highs and even closer to the 24,000 mark, the Nasdaq took a big step back and gave back all of its gains and then some after tech stocks took a dive. Crude oil took a step back again on Wednesday. The S&P 500 sectors were practically all positive in the session with a couple of exceptions. The best performing sectors were financials, industrials, and energy, up 1.7%, 0.9% and 0.6%, respectively. The worst performing sectors were technology and real estate down 2.2% and 0.2%, respectively.

Top 10 Performing Stocks For 2018: Limelight Networks Inc.(LLNW)

Advisors’ Opinion:

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)

Top 10 Performing Stocks For 2018: Frontline Ltd.(FRO)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Frontline Ltd. (NYSE: FRO) is projected to post a loss in the second quarter, translating to a zero dividend, Credit Suisse said in a Tuesday note. Notwithstanding the negative opinion, the shares of the company were up in reaction to the possibility of a deal being struck.

  • [By Lisa Levin]

    Wednesday afternoon, the energy shares surged 1.23 percent. Meanwhile, top gainers in the sector included Frontline Ltd. (NYSE: FRO), up 5 percent, and JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO), up 6 percent.

  • [By Rich Smith]

    So what is it that’s supporting DHT’s stock price in the face of sliding shipping rates for crude oil, retreating revenue, and plunging profits? Well, for one thing, rival tanker companyFrontline (NYSE:FRO) made an unsolicited bid to acquire DHT last week, offering to pay $475 million for the company. (DHT is currently valued at $460 million.)

Top 10 Performing Stocks For 2018: Synacor, Inc.(SYNC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Synacor Inc (NASDAQ: SYNC) shares dropped 18 percent to $3.42. Synacor priced 5.715 million shares at $3.50 per share.

    Shares of Resources Connection, Inc. (NASDAQ: RECN) were down around 15 percent to $13.65 after the company posted downbeat quarterly results.

  • [By Monica Gerson]

    Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.

    VAALCO Energy, Inc. (NYSE: EGY) is expected to post a quarterly loss at $0.11 per share on revenue of $18.59 million.

Top 10 Performing Stocks For 2018: Culp, Inc.(CFI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Our analysis around past CEO transitions shows that in the absence of an inherited bubble, or milked portfolio, both of which are factually absent here when looking at the numbers, balance sheet matters ((Danaher (DHR)) from Culp (CFI) to Joyce/3M (MMM) from Buckley to Thulin), and here incoming CEO Adamczyk has a bazooka at his disposal, a dramatic differentiator. With these resources, stepping away from the 10% EPS growth target would be unnecessarily conservative, and a major misstep early on, as we see plenty of smart ways to enhance long term growth while at the same time maintaining earnings visibility, the most important determinant of a premium multiple in this sector. Honeywell is our top pick.

Top 10 Performing Stocks For 2018: AAON Inc.(AAON)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Aaon Inc. (AAON) is an Oklahoma-based, family-owned and operated firm, with 23.54% insider ownership. It is an excellent business to own for the long term.

Top 10 Performing Stocks For 2018: Broadwind Energy Inc.(BWEN)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Three of the most popular wind energy stocks today are Broadwind Energy Inc. (Nasdaq: BWEN), Gamesa Corporaci贸n Tecnol贸gica SA (OTCMKTS: GCTAF), and Nordex SE (ETR: NDX1).

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday’s regular session.

Top 10 Performing Stocks For 2018: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Paul Ausick]

    Blaming the unwillingness of its target even to discuss a buyout, Emerson Electric Co. (NYSE: EMR) on Tuesday announced that it has withdrawn its unsolicited offer to acquire Rockwell Automation Inc. (NYSE: ROK) for $225 a share in a deal valued at nearly $30 billion.

  • [By Ben Levisohn]

    Bernstein’s Steven Winoker looks back at 2016 for the industrial stocks he covers–Ingersoll-Rand (IR), Rockwell Automation (ROK), Eaton (ETN), and General Electric (GE) among them–and contemplates what 2017 might hold:

  • [By Lee Jackson]

    These companies also reported insider selling last week: Aetna Inc. (NYSE: AET), Cullen/Frost Bankers Inc. (NYSE: CFR), Rockwell Automation Inc. (NYSE: ROK), Stamps.com (NASDAQ: STMP) and Western Alliance Bancorporation (NYSE: WAL).

Top 10 Performing Stocks For 2018: Microbot Medical Inc. (MBOT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Microbot Medical Inc (NASDAQ: MBOT) shares dropped 34 percent to $2.50. Microbot Medical reported a $10 million registered direct offering

    Shares of NewLink Genetics Corp (NASDAQ: NLNK) were down 12 percent to $11.13 after the company reported that indoximod + PROVENGE resulted in statistically significant improvement in rPFS for patients with mCRPC in Phase 2 trial.

  • [By Lisa Levin]

    Microbot Medical Inc (NASDAQ: MBOT) shares shot up 51 percent to $7.76 after reporting a significant technology patent allowance in the U.S. The patent allowance covers a device for the prevention of shunt stenosis.

  • [By Lisa Levin]

    Shares of Microbot Medical Inc (NASDAQ: MBOT) got a boost, shooting up 15 percent to $8.77 after the company reported a 700,000 share direct offering for $3.5 million.

Top 10 Performing Stocks For 2018: Vanguard Mega Cap Value ETF (MGV)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

Top 10 Performing Stocks For 2018: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Nicholas Rossolillo]

    Wearable devices are quickly becoming mainstream technology, with smartwatches and fitness trackers leading the way. You’d never know that based on the performance of traditional watchmaker Fossil Group (NASDAQ:FOSL) as the company is struggling to adapt to the changing times.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, NVIDIA (NASDAQ:NVDA) and Fossil Group(NASDAQ:FOSL) attracted heavy investor interest following their quarterly earnings reports.

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

  • [By Lisa Levin]

    Fossil Group Inc (NASDAQ: FOSL) was down, falling around 21 percent to $14.32 after the company posted downbeat quarterly results and issued a weak outlook for the second quarter.

stock valuation

Small cap poultry processing stock Sanderson Farms, Inc (NASDAQ: SAFM) reported Q2 2017 earnings before the market opened this morning as shares still have elevated short interest of 27.73% according to Highshortinterest.comdue in part to fears over bird flu that have probably subsided. Net sales were $802.0 million versus $692.1million while net income was $66.9 million versus net income of $47.6 million. Overall market prices for poultry products were higher during the second quarter compared with the same period last year while market prices for chicken products sold to retail grocery store customers remained relatively strong during the quarter and continue to reflect good demand. The earnings release noted:

Compared with the second fiscal quarter of 2016, boneless breast meat market prices were approximately 9.1 percent higher, the average market price for bulk leg quarters increased approximately 17.2 percent, and jumbo wing market prices were higher by 5.1 percent. The Company’s average feed costs per pound of poultry products processed were essentially flat when compared with the second quarter of fiscal 2016, while prices paid for corn and soybean meal, the Company’s primary feed ingredients, decreased 0.4 percent and increased 15.0 percent, respectively, compared with the second quarter of fiscal 2016. The Company’s feed costs per pound processed were affected by changes in feed formulation and improved broiler performance.

stock valuation: Rockwell Automation, Inc.(ROK)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week: Aetna Inc. (NYSE: AET), Cullen/Frost Bankers Inc. (NYSE: CFR), Rockwell Automation Inc. (NYSE: ROK), Stamps.com (NASDAQ: STMP) and Western Alliance Bancorporation (NYSE: WAL).

  • [By Lisa Levin]

    Breaking news

    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
    Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
    NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
    Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock.

  • [By Paul Ausick]

    Blaming the unwillingness of its target even to discuss a buyout, Emerson Electric Co. (NYSE: EMR) on Tuesday announced that it has withdrawn its unsolicited offer to acquire Rockwell Automation Inc. (NYSE: ROK) for $225 a share in a deal valued at nearly $30 billion.

  • [By Ben Levisohn]

    Bernstein’s Steven Winoker looks back at 2016 for the industrial stocks he covers–Ingersoll-Rand (IR), Rockwell Automation (ROK), Eaton (ETN), and General Electric (GE) among them–and contemplates what 2017 might hold:

stock valuation: Eagle Bancorp, Inc.(EGBN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Eagle Bancorp Inc. (NASDAQ: EGBN) dropped 28% Friday to post a new 52-week low of $47.65 after closing at $66.15 on Thursday. The stock’s 52-week high is $69.80. Volume of around 3.6 million was more than three times the daily average. The bank holding company had no specific news Friday.

  • [By Lisa Levin]

    On Monday, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Eagle Bancorp, Inc. (NASDAQ: EGBN) and BankUnited (NYSE: BKU).

stock valuation: Biotricity (BTCY)

Advisors’ Opinion:

  • [By Peter Graham]

    Finally, small cap Biotricity (OTCQB: BTCY)is an entirely different wearables play as its a medical technology company whos mission is to revolutionize chronic care management by developing innovative solutions that bridge the gap between diagnostic care and disease management. More specifically, biotricity is focused on delivering innovative, remote biometric monitoring solutions to the healthcare and consumer markets -including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. biotricitys R&D is focused on the preventative healthcare market as the company aims to support the self-management of critical and chronic conditions to ease the growing burden on the healthcare system.

  • [By James E. Brumley]

    Biotricity Inc (OTCMKTS:BTCY), a developer of remote health-monitoring devices, reminded us not so gently today that while it’s waiting on the last of the necessary approvals from the FDA for its hardware, it’s still moving the ball downfield (so to speak). That is to say, it’s already lined up a manufacturer for its so-called Bioflux cardiac monitor for when the last green light is given, and it’s a good one…. Providence Enterprise . That’s the same company that makes some of the equipment and goods within your sight right now.

    Biotricity is the name behind two pieces of technology, both of which are nearing the end of their development. One is the aforementioned Bioflux, and the other is called biolife…. the latter for use by individuals outside of a clinical setting. Neither is on the market yet, but both are projected to be on the market this year. In fact, the company demonstrated its IoT-connected bioflux at this year’s Mobile World Congress (MWC) 2017 in Barcelona, Spain a couple of weeks ago. The crowd liked what it saw.

    The marketable version of the device isn’t available yet; it’s still going through the approval process. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device, and that portion of the review takes longer.

    Still, the company is rightfully optimistic, so much so that it’s already lined up a company to manufacture the Bioflux device once the final approval and final specs are in. That company is Providence Enterprise, which has a long history in making drug delivery and diagnostic equipment, as well as plenty of experience making electronics. The Bioflux will be a blend of both capabilities.

    It’s in

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By Matthew Briar]

    Biotricity Inc (OTCMKTS:BTCY) announced on Tuesday morning it was teaming up with Global to Local (G2L) to develop remote monitoring solutions that not only work, but serve the underserved (medically speaking) community. This partnership is of particular interest to current and would-be BTCY investors, as it will likely validate the crux of the work the company has done thus far.

    Biotricity is the developer of two different though related technologies. One is called bioflux, and the other is called biolife. Both are heart-monitoring devices… the former for use by caregivers in a clinical setting, while the latter is for use by individuals outside of a clinical setting. Neither is on the market yet, but both are projected to be on the market next year. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device.

    The technology is unique, in that it not only provides stunningly accurate detailed information about a patient’s heart function, but it constantly feeds that data – remotely – to a caregiver and monitor that can make good use of that data. In August the company announced AT&T Inc. (NYSE:T) would be handling the wireless (cellular) connectivity between clinics and patients’ bioflux devices.

    It’s a breakthrough, for many reasons, not the least of which is that remote monitoring lowers overall healthcare costs for those patients, and ultimately, for insurers.

    The hardware is not yet available on a commercial basis, but it is being tested in a clinical setting. The Global to Local partnership will be another field test of sorts, validating the work Biotricity has performed on the R&D front.

    The organization says

  • [By James E. Brumley]

    While the economy’s natural — and recurring — cycles favor different kinds of stocks at different times, not every great trend is necessarily a cyclical one. Sometimes, a trend is rooted in a technological development that changes cultural norms. The advent of the smartphone, for example, has made constant connectivity to the world around part of how we live our daily lives.

    These mega-trends present tremendous opportunities for investors too, provided they’re savvy enough to see them coming and play them the right way.

    One such mega-trend newly underway right now is the proliferation of wearables… devices that meld clothing (often a wrist-worn device) and technology to perform a function that couldn’t be performed otherwise. Much of the same technology that made the smartphone possible are now ushering in wearables.

    It’s not been a smooth beginning. however.

    While the buzz was strong and expectations reached a peak two years ago when Fitbit Inc (NYSE:FIT) was all the rage and in the wake of its IPO, the company’s growth wasn’t to be sustained. The company is struggling to muster any growth now, and FIT shares have fallen to a tenth of their value seen in late-2015, when the euphoria was strongest.

    Fitbit’s slowdown has been mirrored by other companies in the space. The wearables market only grew 3.1% in Q3 of 2016.

    On the flipside, while the debacle of Fitbit — the wearable industry’s iconic company — has been a painful, it’s also been a learning experience. And, it’s not as if the slowdown is unfurling without the wearables market never reaching a respectable size. International Data Corporation estimates were 23 million ‘wearables’ delivered in the third quarter of last year alone.

    Moreover, the fizzling of the market hasn’t turned into a reason to swear off wearables as an investment opportunity… quite the opposite, actually. It’s just now become considerably clearer what consumers want an

stock valuation: Computer Programs and Systems Inc.(CPSI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Computer Programs & Systems, Inc. (NASDAQ: CPSI) were down 31 percent to $27.00 after the company posted weaker-than-expected Q2 results.

stock valuation: Roadrunner Transportation Systems, Inc(RRTS)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was another down day for the Dow Jones Industrials, which fell more than 100 points to drop further below the 20,000 level. But broader market measures were mixed, and the Nasdaq Composite even managed to gain ground. Continued uncertainty about the impact of new policies from the U.S. federal government have kept markets a bit turbulent, and the beginning of a two-day meeting of the Federal Reserve’s Open Market Committee could set the tone for monetary policy in 2017. Some stocks had bad news that sent them lower today, and among the worst performers were Seadrill (NYSE:SDRL), Roadrunner Transportation Systems (NYSE:RRTS), and Tempur Sealy International (NYSE:TPX). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

stock valuation: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Even as there is a scramble toward achieving $1 trillion market cap, Benzinga looked at United States Steel Corporation (NYSE: X), which was the first company ever to be capitalized at over $1 trillion. The history of the steel maker is a checkered one, and over the years, it has lost its shine and appeal and is currently looking a pale shadow of its old self.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

  • [By Lee Jackson]

    This is the granddaddy of the domestic steel producers and another stock rated Buy at Deutsche Bank.United States Steel Corp. (NYSE: X) is an integrated producer of flat carbon steel and pipe with a total 22million tons of capacity in North America and Slovakia.

  • [By Merrick Weingarten]

    Steel stocks were up big on Tuesday ahead of the Department of Commerce hearing on the Section 232 probe. The DoC is set to come out with more details regarding the impact steel imports has on U.S. national security.

    Stock Movements
    United States Steel Corporation (NYSE: X): Up 5.27 percent. AK Steel Holding Corporation (NYSE: AKS): Up 9.55 percent. Nucor Corporation (NYSE: NUE): Up 3.54 percent. Steel Dynamics, Inc. (NASDAQ: STLD): Up 4.08 percent. Worthington Industries, Inc. (NYSE: WOR): Up 3.29 percent.
    Analyst Commentary

    A Jefferies research analyst suggested a high probability of the DoC institutes more incremental trade defense measures but noted most of the investigation remains unknown going into Wednesday.